To explore whether that the use of NSAIDs in the RA groups exerts a significant influence on gut permeability, we assessed gut permeability markers such as zonulin, FABP2, and LBP in plasma and feces of naive RA patients with NSAIDs. This evidence concerns the gene FABP2 and rheumatoid arthritis.